2023
DOI: 10.1039/d2dt03548k
|View full text |Cite
|
Sign up to set email alerts
|

Novel candidate theranostic radiopharmaceutical based on strontium hexaferrite nanoparticles conjugated with azacrown ligand

Abstract: In this article, we report the first to the best of our knowledge modification of NPs with ligands for combined radiopharmaceuticals. Nanoparticles with suitable magnetic properties can be used both...

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
5

Relationship

1
4

Authors

Journals

citations
Cited by 5 publications
(2 citation statements)
references
References 78 publications
0
2
0
Order By: Relevance
“…Earlier, we have developed a strategy for the synthesis of the bifunctional derivative of similar pyridine azacrown ether . The ligand has been bound with nanoparticles via the group associated with pyridine, and the final conjugate was successfully labeled. , …”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Earlier, we have developed a strategy for the synthesis of the bifunctional derivative of similar pyridine azacrown ether . The ligand has been bound with nanoparticles via the group associated with pyridine, and the final conjugate was successfully labeled. , …”
Section: Discussionmentioning
confidence: 99%
“…55 The ligand has been bound with nanoparticles via the group associated with pyridine, and the final conjugate was successfully labeled. 56,57 Taken together, H 4 BATA is a superior candidate for further conjugation with antibodies and for the application in radioimmunotherapy by a 225 Ac radionuclide. Additionally, H 4 BATA can be used for La 3+ complexation, meaning the possibility of combination of 225 Ac and 132,133,135 La radioisotopes for theranostic application.…”
Section: ■ Conclusionmentioning
confidence: 99%